Cardiovascular stents - Biomaterials and Devices for the Circulatory System - page 203

GUTENSOHN K, BEYTHIEN C, BAU J, FENNER T, GREWE P, KOESTER R, PADMANABAN K
and KUEHNL P. In vitro analyses of DLC coated stents. Reduction of metal ion
release, platelet activation, and thrombogenicity. Thrombosis Res 2000; 15 :
577-585.
HAASE J, STÖRGER H, HOFMANN M, SCHWARZ CE, REINEMER H and SCHWARZ F. Compari-
son of stainless steel stents coated with turbostatic carbon and uncoated stents
for percutaneous coronary interventions. J Invasive Cardiol 2003; 15 (10):
566-567.
HANAWA T. Evaluation techniques of metallic biomaterials in vitro . Sci Technol Adv
Mater 2002; 3 : 289-295.
HARMAND MF. In vitro study of biodegradation of a Co-Cr alloy using a human cell
culture. J Biomed Mater Res: Sci Polym Ed 1994; 6 : 809-814.
HASEBE T, YOHENA S, KAMIJO A, OKAZAKI Y, HOTTA A, TAKAHASHI K, et al. Fluorine doping
into diamond-like carbon coatings inhibits protein adsorption and platelet activa-
tion. J Biomed Mat Res A 2007; 83 : 1192-1199.
HAUDE M, KONORZA TFM, KALNINS U, ERGLIS A, SAUNAMÄKI K, GLOGAR HD, GRUBE E, GIL
R, SERRA A, RICHARDT HG, SICK P, ERBEL R, for the heparin COAted Stents in small
coronary arteries (COAST) Trial Investigators. Heparin-coated placement for the
treatment of stenosis in small coronary arteries of symptomatic patients. Circula-
tion 2003; 107 : 1265-1270.
HBS CONSULTING. New trends in cardiology devices: what is the future of stents?
http://hbs-consulting.com/HBSQuarterly/hbsq8a2.asp (accessed 4 September
2009).
HEHRLEIN C, ZIMMERMANN M, METZ J, et al. Radioactive coronary stent implantation
inhibits neointimal proliferation in nonatherosclerotic rabbits (Abstr). Circula-
tion 1993; 88 : II-651.
HEHRLEIN C, GOLLAN C, DONGES K, METZ J and FEHSENFELD P. Low dose radioactive
endovascular stents prevent smooth muscle cell proliferation and neointimal
hyperplasia in rabbits. J Am Coll Cardiol 1995; 9a : 901-919.
HEHRLEIN C, STINTZ M, KINSCHERF R, SCHLOSSER K, HUTTEL E, FRIEDRICH L, FEHSENFELD
P and KUBLER W. Pure beta-particle-emitting stents inhibit neointima formation
in rabbits. Circulation 1996; 93 : 641-645.
HEHRLEIN C, DEVRIES JJ, ARAB A, HALLER SD, SCHLOESSER K, TIO FO and FI SCHELL TA.
Failure of a novel balloon-expandable gamma-emitting ((103) Pd) stent to prevent
edge effects. Circulation 2001; 104 : 2358-2362.
HEINTZ C, RIEPE G, BIRKEN L, KAISER E, CHAKFÉ N, MORLOCK M, DELLING G and IMIG H.
Corroded Nitinol wires in explanted aortic endografts: an important mechanism
of failure. J Endovasc Ther 2001; 8 (3): 248-253.
HERMAN RA, RYBNIKAR A, RESCH A, MARKI B, ALT E and STEMBERGER A. Thrombogenicity
of stainless steel coronary stents with a completely gold coated surface. JACC
1998; Suppl. (Feb): 413A.
HEUBLEIN B, ROHDE R, KAESE V, NIEMEYER M, HARTUNG W and HAVERICH A. Biocorrosion
of magnesium alloys: a new principle in cardiovascular implant technology? Heart
2003; 89 : 651-656 doi: 10.1136/heart.89.6.651.
HIJAZI ZM, HOMOUD M, ARONOVITZ MJ, SMITH JJ and FALLER GT. A new platinum bal-
loon-expandable stent (Angiostent) mounted on a balloon: acute and late results
in an atherogenic swine model. J Invas Cardiol 1995; 7 (5): 127-134.
HOLMES D, CAMRUD A, JORGENSON M, EDWARDS W and SCHWARTZ R. Polymeric stenting
in the porcine coronary artery model: differential outcome of exogenous fi brin

￿ ￿ ￿ ￿ ￿